Skip to main content

Members

We have more than 140 members from 23 different countries across the world, including representation from 10 LMICs.

 

Members come from academic institutions, industry, government bodies, and the not-for-profit sector. It's this diversity and breadth of knowledge that supports our vision of accelerating vaccine development through human infection challenge studies. 

Benefits of becoming a Network member include:

  • Joining an international community of researchers to improve vaccine development for global diseases
  • Access to potential collaborators from multidisciplinary fields
  • Networking opportunities at our Annual Meeting
  • Members are eligible to apply for pump-priming funding of up to £100,000 and training awards of up to £5,000
  • Notification of news, events, training, funding and publications of interest via email

 

Find out how to become a member here.